VANCOUVER, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today reported financial results… Read More
VANCOUVER, BC –/PRNewswire/ — Dr. YongHua Li conducted a clinical trial for EmeTerm, the anti-nausea wristband developed by WAT Medical Enterprise, Ltd., Vancouver, BC, Canada. The study spanned across three… Read More
The Skilled Newcomer Internships for the Bio-economy is now accepting applicants. Canada’s bio-economy must become more diverse if the industry is to reach the talent needs of the next decade…. Read More
New board members bring significant leadership experience in the biotech sector VANCOUVER, BC — Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we… Read More
Evusheld significantly reduced risk of severe COVID-19 or death in TACKLE Phase III treatment trial AstraZeneca’s Evusheld (tixagevimab and cilgavimab, formerly AZD7442), a long-acting antibody combination, has been approved in the European… Read More
